Top of this page
Skip navigation, go straight to the content

Newsroom Press Releases

Search Press releases


Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira[®]06 Dec 2019

Bimekizumab Phase 3 Psoriasis Study Demonstrates Superiority Versus Humira …

Read more
Bimekizumab Positive Results Confirmed in Second Phase 3 Psoriasis Study15 Nov 2019

Bimekizumab Positive Results Confirmed in Second Phase 3 Psoriasis Study …

Read more
Transparency notifications BlackRock, Inc.08 Nov 2019

Transparency notifications BlackRock, Inc.

Read more
UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs in Axial Spondyloarthritis, Psoriatic Arthritis and Lupus at 2019 ACR/ARP08 Nov 2019

UCB Presents New Data From Rheumatology Portfolio Addressing Unmet Needs …

Read more
Transparency notification Vanguard Health Care Fund18 Oct 2019

Transparency notification Vanguard Health Care Fund

Read more
EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of Severe Osteoporosis in Postmenopausal Women at High Risk of Fracture18 Oct 2019

EVENITY® (romosozumab) Receives Positive CHMP Opinion for the Treatment of …

Read more


Stay up-to-date on the latest news and information from UCB